Long-time EquipNet client, Eli Lilly, is partnering with German pharmaceutical company, Boehringer Ingelheim, to develop and commercialize a pipeline of diabetes compounds estimated to generate more than EUR 10 billion in peak sales.
Check out the Wall Street Journal article to get all the details of this strategic alliance.